.png)
Eyes On Alzheimer's, Epilepsy, Immunology, and Obesity
This week, we had eyes on data readouts, launch metrics, M&A, and more. Catch up with the news from Roche, AstraZeneca, Lundbeck, and AbbVie
top of page
Eyes on Pharma
Check-out What Intel Caught our Eye
Jana Chisholm
Nov 174 min read
Eyes on Sanofi, Regeneron, Novo Nordisk, and Pfizer
We've had Eyes On some of the recent deals, results, and investor actions. Check out the happenings at Sanofi/Opella, Pfizer, Regeneron, and
Jana Chisholm
Nov 15 min read
Eyes On October M&A activities, Approvals, and more
Last month, we had Eyes On some of the latest approvals, M&A and litigation. Read more about AbbVie, Genentech, Lundbeck, and GSK ...
Jana Chisholm
Oct 56 min read
Eyes on BMS, Pfizer, & Amgen
Eye's on the Amgen data releases for gMG & Atopic Dermatitis, the BMS approval of Cobenfy for schizophrenia, and Pfizer's Oxbryta recall...
Jana Chisholm
Sep 205 min read
Eyes on BioPharma Headlines
This month, we've had Eyes on investment trends, strategic restructuring, and FDA decisions. Fall seems to be gearing up, and we can't wait
Jana Chisholm
Sep 65 min read
August News Highlights
We've had our Eyes On some of the latest Pharmaceutical news including approvals, partnering, mergers, research programs, and
Jana Chisholm
Jul 175 min read
Eyes On the Competition
his week we've been looking at the competition heating up due to a combination of M&A, biosimilar entrants, and new clinical data ...
Jana Chisholm
Jun 183 min read
Eyes on ASCO 2024
The ASCO 2024 annual meeting took place from 31st May to 4th June. A number of firms presented data, and others used this as an opportunity
jroele
Jun 72 min read
Our Comments & Links on Top 4 Biggest Drugs in 2023
Check out this Top Drugs of 2023 list with links to interesting reports in PharmaTell Studio. Contact us for a trial.
Jana Chisholm
Jun 54 min read
Eyes on Recent News from BioPharma + a 2023 Top WW 2023 List
This week we've had eyes on BioPharma happenings plus a 2023 Top Selling Drugs list.
Jana Chisholm
May 185 min read
Eyes on Pharma Restructures + Pfizer's Clinical SAE
We've had Eyes On recent news further clarifying company restructures. In the midst of refining pipelines, and cutting corporate spending ..
Jana Chisholm
May 24 min read
1Q24 BioPharma Deals & Raises
We've been keeping Eyes On Deals & Raises in the BioPharma sector for the first quarter of 2024. Things seem to be heating-up ...
Jana Chisholm
Apr 163 min read
Eyes on Corporate Restructuring
Lately we've been keeping Eyes On the corporate restructuring in the BioPharma sector. We've seen Big Pharma and BioTech refocusing ...
Jana Chisholm
Mar 244 min read
Eyes on Current Events - Deals, Approvals & Operations
We've been trying to keep up with current events - here's some of what we've hay Eyes On this week.
Jana Chisholm
Mar 113 min read
Eyes On Healthcare Headlines
Some of the highlights include AI medical advancements, strategic industry movements, regulatory updates, & challenges within the pharma ...
Jana Chisholm
Feb 83 min read
Eyes on BioPharma Portfolio Strategies
This week we've had Eyes how BioPharma are bolstering their Portfolios for long-term success. From licensing assets ...
Jana Chisholm
Jan 223 min read
Eyes on the New Year - 2024 has a Busy Start with Deals and Approvals
2024 is off to a busy start with M&A activities highlighted at the JP Morgan Healthcare Conference, plus another Genetic Medicines approval.
Jana Chisholm
Dec 1, 20233 min read
Eyes on Clinical Trial Data, Supply Upgrades, and Patent Litigation
The news this week was full of "Ups-n-Downs." We've noted a few here and know there were more surprises with clinical data results, M&A, and
Jana Chisholm
Nov 24, 20233 min read
Eyes on Casgevy, Pfizer & More
Some of this week's news includes Casgevy Approval, Novo's REDEFINE 4 Trial, , new Manufacturing plant and more.
Robin Bateman
Jul 10, 20231 min read
Medical Conferences
We have Eyes on Pharma Conferences this week. Don't forget to check PharmaTell Studio for the latests Planners, Insights, and Key Takes.
bottom of page